BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17202828)

  • 1. Effectiveness of cetuximab/gefitinib in the therapy of a sacral chordoma.
    Hof H; Welzel T; Debus J
    Onkologie; 2006 Dec; 29(12):572-4. PubMed ID: 17202828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct intratumoral chemotherapy with carboplatin and epinephrine in a recurrent cervical chordoma: case report.
    Guiu S; Guiu B; Feutray S; Chauffert B
    Neurosurgery; 2009 Sep; 65(3):E629-30; discussion E630. PubMed ID: 19687674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A small prospective study of chordomas treated with radiotherapy and razoxane.
    Rhomberg W; Böhler FK; Novak H; Dertinger S; Breitfellner G
    Strahlenther Onkol; 2003 Apr; 179(4):249-53. PubMed ID: 12707714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation therapy for chordomas of the base of skull and cervical spine: patterns of failure and outcome after relapse.
    Fagundes MA; Hug EB; Liebsch NJ; Daly W; Efird J; Munzenrider JE
    Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):579-84. PubMed ID: 7558946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current management of sacral chordoma.
    Fourney DR; Gokaslan ZL
    Neurosurg Focus; 2003 Aug; 15(2):E9. PubMed ID: 15350040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sacral chordoma: retrospective review of 11 surgically treated cases].
    Jeanrot C; Vinh TS; Anract P; De Pinieux G; Ouaknine M; Forest M; Tomeno B
    Rev Chir Orthop Reparatrice Appar Mot; 2000 Nov; 86(7):684-93. PubMed ID: 11104990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definitive high-dose photon/proton radiotherapy for unresected mobile spine and sacral chordomas.
    Chen YL; Liebsch N; Kobayashi W; Goldberg S; Kirsch D; Calkins G; Childs S; Schwab J; Hornicek F; DeLaney T
    Spine (Phila Pa 1976); 2013 Jul; 38(15):E930-6. PubMed ID: 23609202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of risk factors for recurrence after the resection of sacral chordoma combined with embolization.
    Yang H; Zhu L; Ebraheim NA; Liu X; Castillo S; Tang T; Liu J; Cui H
    Spine J; 2009 Dec; 9(12):972-80. PubMed ID: 19800296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of cervical spinal cord compression in a patient with chordoma following treatment with cetuximab and gefitinib.
    Lindén O; Stenberg L; Kjellén E
    Acta Oncol; 2009; 48(1):158-9. PubMed ID: 18752082
    [No Abstract]   [Full Text] [Related]  

  • 10. Intensity modulated radiotherapy in the management of sacral chordoma in primary versus recurrent disease.
    Zabel-du Bois A; Nikoghosyan A; Schwahofer A; Huber P; Schlegel W; Debus J; Milker-Zabel S
    Radiother Oncol; 2010 Dec; 97(3):408-12. PubMed ID: 21056488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chordoma (a review of 11 cases)].
    De Santis E; Gasparini G; Pallotta F; Lisai P
    Arch Putti Chir Organi Mov; 1990; 38(1):133-46. PubMed ID: 2101215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Image-guided percutaneous lipiodol-pingyangmycin suspension injection therapy for sacral chordoma.
    Huang D; Chen Y; Zeng Q; Wu R; Li Y
    Korean J Radiol; 2013; 14(5):823-8. PubMed ID: 24043980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome following surgical treatment of sacral chordoma.
    Osaka S; Osaka E; Kojima T; Yoshida Y; Tokuhashi Y
    J Surg Oncol; 2014 Mar; 109(3):184-8. PubMed ID: 24249252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chordomas of the craniospinal axis: multimodality surgical, radiation and medical management strategies.
    Muro K; Das S; Raizer JJ
    Expert Rev Neurother; 2007 Oct; 7(10):1295-312. PubMed ID: 17939768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers.
    Stacchiotti S; Casali PG; Lo Vullo S; Mariani L; Palassini E; Mercuri M; Alberghini M; Pilotti S; Zanella L; Gronchi A; Picci P
    Ann Surg Oncol; 2010 Jan; 17(1):211-9. PubMed ID: 19847568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sacral chordomas: Impact of high-dose proton/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor.
    Park L; Delaney TF; Liebsch NJ; Hornicek FJ; Goldberg S; Mankin H; Rosenberg AE; Rosenthal DI; Suit HD
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1514-21. PubMed ID: 16757128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decision making in primary sacral tumors.
    Puri A; Agarwal MG; Shah M; Srinivas CH; Shukla PJ; Shrikhande SV; Jambhekar NA
    Spine J; 2009 May; 9(5):396-403. PubMed ID: 19059810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of carbon ion radiotherapy for sacral chordoma: results of Phase I-II and Phase II clinical trials.
    Imai R; Kamada T; Tsuji H; Sugawara S; Serizawa I; Tsujii H; Tatezaki S;
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1470-6. PubMed ID: 19939576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dedifferentiated chordoma arising in irradiated sacral chordoma.
    Ikeda H; Honjo J; Sakurai H; Mitsuhashi N; Fukuda T; Niibe H
    Radiat Med; 1997; 15(2):109-11. PubMed ID: 9192436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypofractionated stereotactic radiation therapy for skull base and upper cervical chordoma and chondrosarcoma: preliminary results.
    Gwak HS; Yoo HJ; Youn SM; Chang U; Lee DH; Yoo SY; Rhee CH
    Stereotact Funct Neurosurg; 2005; 83(5-6):233-43. PubMed ID: 16601376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.